Fairvalue-Calculator Fairvalue-Calculator
EN DE

IRIDEX Corporation (IRIX) Fair Value & Analysis

Healthcare · US · Market cap $19.7M

Price$1.18
Fair Value$1.27
Upside+7.6%
Quality95/100
Evidence: Low Range $0.9500 – $1.59

Fair value as of: Jun 24, 2026

Analysis

IRIDEX Corporation (IRIX) currently trades at $1.18, while our model-based Fair Value estimate is $1.27 — implying the stock looks roughly 7.6% undervalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: low) — always confirm before acting.

About the company

IRIDEX Corporation, an ophthalmic medical technology company, provides therapeutic based laser systems, delivery devices, and consumable instrumentation to treat sight-threatening eye diseases in ophthalmology. It offers laser consoles, such as Cyclo G6 laser system for use in the treatment of glaucoma; IQ 532 and IQ 577 laser systems, which are used for the treatment of retinal disorders; and OcuLight TX, OcuLight SL, OcuLight SLx, OcuLight GL, and OcuLight GLx laser photocoagulation systems that are used to treat proliferative diabetic retinopathy, macular holes, retinal tears, and detachments. The company also provides delivery devices, including slit lamp adapter, which allows the physician to utilize a standard slit lamp in diagnosis and treatment procedures; TxCell scanning laser delivery system that allows the physician to perform multi-spot pattern scanning; and laser indirect ophthalmoscope for use in procedures to treat peripheral retinal disorders. In addition, it offers …

Open the full interactive analysis →

Similar stocks

Abbott Laboratories, (ABT) -23% Stryker Corporation (S1YK34) -89% Medtronic plc (MDT) -7% Boston Scientific Corporation (B1SX34) -81% Edwards Lifesciences Corporation (EW) -53% Siemens Healthineers AG (SEMHF) +11%

Frequently asked questions

Is IRIDEX Corporation (IRIX) undervalued?
As of Jun 24, 2026, our model estimates a fair value of $1.27 versus a price of $1.18 — about +8% (undervalued). Model-based estimate, not financial advice.
What is the fair value of IRIX?
Our 21-model fair value for IRIDEX Corporation is $1.27 (as of Jun 24, 2026), built from audited fundamentals. The current price is $1.18.
What is the quality score of IRIX?
IRIDEX Corporation has a Quality Score of 95/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.